ORLANDO, Fla, March 29 (Reuters) - AstraZeneca’s (AZN.L)(AZN.N) powerful cholesterol drug Crestor cut the risk of dangerous blood clots in the vein by 43 percent, researchers said on Sunday in a study that shows yet more benefits from widely used statin drugs.
